www.3m.com/3M/en_US/health-information-systems-us The value for our organization comes from three things: depth of research, specificity of segments and being easy to work with
466 One study proposed a novel mechanism wherein postprandial GLP-1 release, under normal physiological conditions, inhibits the activity of chemosensory cells in the carotid body, thereby counteracting sympathetic excitability mediated by elevated blood glucose or insulin levels
The article says Contrave is contraindicated in uncontrolled hypertension, seizure disorder, current or prior anorexia or bulimia, and in anyone taking monoamine oxidase inhibitors
Worsening metabolic disease from regain increases healthcare utilization, medication costs for diabetes and cardiovascular conditions, and potential surgical interventions
Realistic Final Outcomes At the 12mg dose, average total weight loss reaches 24.2% of starting body weight
Phase 3 TRIUMPH adds an intermediate 6 mg step and treats 4 mg, 9 mg, and 12 mg as target maintenance doses depending on the trial arm
